Clinical Trial Update: CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma. [Phase 1]

View source ↗

Summary

Clinical trial update for CPD-DARA in relapsed/refractory multiple myeloma; the Phase 1 study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CPD-DARA

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Multiple Myeloma | Phase 1 | Status: ACTIVE_NOT_RECRUITING